Clinical Trials

Toll-Free: 866.320.4573

Call Us Toll Free:

866.223.2273 x1234

Dopamine in Acute Decompensated Heart Failure II

Study:

Comparison of High-dose Furosemide, Low-dose Furosemide, and the Combination of Low-dose Furosemide and Low-dose Dopamine in Patients With Acute Decompensated Heart Failure

Rationale:

n/a

Purpose:

The aim of this study is to compare the effects of 1) high-dose furosemide, 2) low-dose furosemide, and 3) low-dose furosemide combined with low-dose dopamine on diuresis, clinical status, renal function, electrolyte balance, length of stay, and 60-day post-discharge outcomes in patients hospitalized with acute decompensated heart failure.

Study Status: Terminated

Recruiting:
n/a

Condition Intervention Phase
Acute Decompensated Heart Failure Drug: High-dose furosemide
Drug: Low-dose furosemide
Drug: Low-dose furosemide combined with low-dose dopamine
Phase 4

Verified by Larissa University Hospital September, 2013

Sponsored by: Larissa University Hospital
Information provided by: Larissa University Hospital
ClinicalTrials.gov identifier: NCT01060293

Study Type: Interventional

Study Design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

The Cleveland Clinic Foundation
Cleveland, Ohio
United States

Gregory Giamouzis, MD., Study Chair
Filippos Triposkiadis, MD., Study Chair

This information is abridged to display results relevant only to Cleveland Clinic. To see complete record visit ClinicalTrials.gov
  Information obtained from ClinicalTrials.gov on
Link to the current ClinicalTrials.gov record.

Cleveland Clinic Mobile Site